Sarcopenia in Latin America: Current Challenges in the Face of an Emerging Public Health Problem
Article Sidebar
Main Article Content
Abstract
Sarcopenia is an increasing public health concern in Latin America, driven by aging, socioeconomic inequalities, and nutritional changes. It is now defined as a muscle disease with functional impact and higher mortality. Addressing it requires regional data, specific diagnostic criteria, and further research to improve detection and health policies.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista utiliza la licencia Creative Commons BY-NC-SA (Reconocimiento-No Comercial-Compartir Igual), que permite a los usuarios compartir y adaptar el material publicado bajo ciertas condiciones. Los autores deben ser reconocidos de acuerdo con los términos establecidos por la licencia, y los trabajos derivados solo pueden ser utilizados para fines no comerciales.
Los autores conservan el derecho de reutilizar, reproducir y difundir su trabajo en otras publicaciones o repositorios, siempre que se respeten los términos de la licencia mencionada y se cite la publicación original en la revista.
References
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://www.doi.org/10.1093/ageing/afy169. Erratum in: Age Ageing. 2019;48(4):601. https://www.doi.org/10.1093/ageing/afz046.
Prado CM, Anker SD, Coats AJS, Laviano A, von Haehling S. Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire. J Cachexia Sarcopenia Muscle. 2021;12(1):3-8. https://www.doi.org/10.1002/jcsm.12673.
Hsu YH, Jones G. Sarcopenia as a predictor of incident disability, institutionalization, and mortality in older adults (Concord Health and Ageing in Men Project). J Am Med Dir Assoc. 2019;16(7), 546–553.
Vaishya R, Gupta BM, Misra A, Mamdapurj GM, Vaish A. Global research in sarcopenia: High-cited papers, research institutions, funding agencies and collaborations, 1993-2022. Diabetes Metab Syndr. 2022;16(11):102654. https://www.doi.org/10.1016/j.dsx.2022.102654.
Karavaski N, Ernst G, Zuccotti A, Reynoso C, Young P, Curriá M. Prevalencia de sarcopenia en adultos sanos mediante el uso de bioimpedancia. Medicina. 2025;85(3):518-525.
Pinheiro L, Rossi M, Dos Santos C, et al. Prevalence of associations among sarcopenia, obesity, and metabolic syndrome in Brazilian older adults. Front Med. 2023;8;10:1206545. HTTPS://WWW.DOI.ORG/10.3389/fmed.2023.1206545.
Pérez-Sousa MÁ, Pozo-Cruz JD, Cano-Gutiérrez CA, Izquierdo M, Ramírez-Vélez R. High Prevalence of Probable Sarcopenia in a Representative Sample From Colombia: Implications for Geriatrics in Latin America. J Am Med Dir Assoc. 2021;22(4):859-864.e1. https://www.doi.org/10.1016/j.jamda.2020.10.021.
Godínez-Escobar K, Gallegos-De Luna C, Meneses-Acero I, et al. Prevalencia de sarcopenia por grupos etarios en una población de la Ciudad de México. Archivos en Medicina Familiar. 2020:22(1):7-12.
Samper-Ternent R, Reyes-Ortiz C, Ottenbacher KJ, Cano CA. Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study. Aging Clin Exp Res. 2017;29(2):265-272. https://www.doi.org/10.1007/s40520-016-0561-2
Lera L, Albala C, Sánchez H, et al. Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria. J Frailty Aging. 2017;6(1):12-17. https://www.doi.org/10.14283/jfa.2016.117.
Arango-Lopera V, Arroyo P, Gutiérrez- Robledo LM, Pérez-Zepeda MU. Prevalence of sarcopenia in Mexico City. European Geriatric Medicine. 2012;3(3):157-160. https://www.doi.org/10.1016/j.eurger.2011.12.001
Swan L, Warters A, O'Sullivan M. Socioeconomic Inequality and Risk of Sarcopenia in Community-Dwelling Older Adults. Clin Interv Aging. 2021;16:1119-1129. https://www.doi.org/10.2147/CIA.S310774.
Ruel-Bergeron JC, Stevens GA, Sugimoto JD, et al. Global Update and Trends of Hidden Hunger, 1995-2011: The Hidden Hunger Index. PLoS One. 2015;10(12):e0143497. https://www.doi.org/10.1371/journal.pone.0143497.
Kovalskys I, Fisberg M, Gómez G, et al. Energy intake and food sources of eight Latin American countries: results from the Latin American Study of Nutrition and Health (ELANS). Public Health Nutr. 2018;21(14):2535-2547. https://www.doi.org/10.1017/s1368980018001222
Fernández-Gaxiola AC, García-Guerra A, Neufeld LM. Persistent Challenges of Micronutrient Deficiencies in Latin America Need Action. Food Nutr Bull. 2024;45(2_suppl):S7-S10. https://www.doi.org/10.1177/03795721241262136.
Liu G, Jiang S, Xie W, et al. Biomarkers for sarcopenia, muscle mass, muscle strength, and physical performance: an umbrella review. J Transl Med. 2025;23(1):650. https://www.doi.org/10.1186/s12967-025-06575-3.
Barreto EF, Poyant JO, Coville HH, et al. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers. Clin Nutr. 2019;38(3):1362-1367. https://www.doi.org/10.1016/j.clnu.2018.05.031.